Journal of Advanced Biomedical Sciences
JABS
Sun, Feb 23, 2025
[Archive]
Winter 2025
Back to the articles list |
Back to browse issues page
Mahsa Alem1 
, Seyyed Meysam Abtahi Froushani * 2, Nasim Hajighahramani3 , Saied Hosseini-Asl4 , Farhad Pourfarzi4 , Rasoul Nemati5
, Seyyed Meysam Abtahi Froushani * 2, Nasim Hajighahramani3 , Saied Hosseini-Asl4 , Farhad Pourfarzi4 , Rasoul Nemati5
1- Department of Microbiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran
2- Department of Microbiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran ,meysamabtahi@hotmail.com
3- Department of Pharmaceutical Biotechnology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran
4- Digestive Diseases Research Center, Ardabil University of Medical Sciences, Ardabil, Iran
5- Department of Internal Medicine, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
2- Department of Microbiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran ,
3- Department of Pharmaceutical Biotechnology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran
4- Digestive Diseases Research Center, Ardabil University of Medical Sciences, Ardabil, Iran
5- Department of Internal Medicine, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
Abstract: (55 Views)
Background & Objectives: This study explored the immunogenetic perspective underpinning the susceptibility and progression of ulcerative colitis (UC), a form of inflammatory bowel disease (IBD) characterized by chronic auto-inflammatory processes in the gut. This multifactorial disorder occurs in genetically predisposed individuals experiencing dysbiosis, wherein genetic factors contribute to intestinal imbalance and modulate immune pathways. Recent discoveries of novel genetic loci and polymorphisms have highlighted racial diversity in IBD susceptibility. Our research addresses a gap in the literature by examining the association between specific genetic loci and UC susceptibility in a defined ethnic group, aiming to identify and evaluate candidate genetic polymorphisms as part of an immunogenetic assessment to elucidate the mechanisms underlying UC susceptibility and progression.
Materials & Methods: In this case-control study, we evaluated 794 reference sequences (rs) from global, national, and regional ethnic databases, which were utilized for genotyping 150 control subjects via blood samples. We selected and investigated five genetic variants—rs3764147 (LACC1 or C13orf31), rs763780 (IL17F), rs3749171 (GPR35), rs1260326 (GCKR), and rs4077515 (CARD9)—using Amplification-refractory mutation system polymerase chain reaction (ARMs PCR) followed by Sanger sequencing for confirmation in 50 UC patients.
Results: Analysis of the candidate genetic polymorphisms revealed that the LACC1, IL17F, and GPR35 variants were significantly associated with UC, with the primary outcome focusing on this association and the secondary outcome examining the allelic frequencies of the five variants in both groups.
Conclusion: Ultimately, our findings demonstrate that the GPR35 (G protein-coupled receptor 35) rs3749171, IL17F (Interleukin 17F) rs763780, and LACC1 (laccase domain containing 1) rs3764147 variants contribute to UC susceptibility as a polygenic trait in the studied ethnic group. This underscores the potential importance of genetic architecture across different ethnicities, offering valuable biological insights into IBD pathogenesis and guiding future research.
Materials & Methods: In this case-control study, we evaluated 794 reference sequences (rs) from global, national, and regional ethnic databases, which were utilized for genotyping 150 control subjects via blood samples. We selected and investigated five genetic variants—rs3764147 (LACC1 or C13orf31), rs763780 (IL17F), rs3749171 (GPR35), rs1260326 (GCKR), and rs4077515 (CARD9)—using Amplification-refractory mutation system polymerase chain reaction (ARMs PCR) followed by Sanger sequencing for confirmation in 50 UC patients.
Results: Analysis of the candidate genetic polymorphisms revealed that the LACC1, IL17F, and GPR35 variants were significantly associated with UC, with the primary outcome focusing on this association and the secondary outcome examining the allelic frequencies of the five variants in both groups.
Conclusion: Ultimately, our findings demonstrate that the GPR35 (G protein-coupled receptor 35) rs3749171, IL17F (Interleukin 17F) rs763780, and LACC1 (laccase domain containing 1) rs3764147 variants contribute to UC susceptibility as a polygenic trait in the studied ethnic group. This underscores the potential importance of genetic architecture across different ethnicities, offering valuable biological insights into IBD pathogenesis and guiding future research.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)